Literature DB >> 21245084

Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation.

Lauren S Havel1, Chuan-En Wang, Brandy Wade, Brenda Huang, Shihua Li, Xiao-Jiang Li.   

Abstract

An expanded polyglutamine tract (>37 glutamines) in the N-terminal region of huntingtin (htt) causes htt to accumulate in the nucleus, leading to transcriptional dysregulation in Huntington disease (HD). In HD knock-in mice that express full-length mutant htt at the endogenous level, mutant htt preferentially accumulates in the nuclei of striatal neurons, which are affected most profoundly in HD. The mechanism underlying this preferential nuclear accumulation of mutant htt in striatal neurons remains unknown. Here, we report that serine 16 (S16) in htt is important for the generation of small N-terminal fragments that are able to accumulate in the nucleus and form aggregates. Phosphorylation of N-terminal S16 in htt promotes the nuclear accumulation of small N-terminal fragments and reduces the interaction of N-terminal htt with the nuclear pore complex protein Tpr. Mouse brain striatal tissues show increased S16 phosphorylation and a decreased association between mutant N-terminal htt and Tpr. These findings provide mechanistic insight into the nuclear accumulation of mutant htt and the selective neuropathology of HD, revealing potential therapeutic targets for treating this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245084      PMCID: PMC3049362          DOI: 10.1093/hmg/ddr023

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

Review 1.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

Review 2.  Mechanisms of disease: Histone modifications in Huntington's disease.

Authors:  Ghazaleh Sadri-Vakili; Jang-Ho J Cha
Journal:  Nat Clin Pract Neurol       Date:  2006-06

3.  Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Authors:  Caroline L Benn; Christian Landles; He Li; Andrew D Strand; Ben Woodman; Kirupa Sathasivam; Shi-Hua Li; Shabnam Ghazi-Noori; Emma Hockly; Syed M N N Faruque; Jang-Ho J Cha; Paul T Sharpe; James M Olson; Xiao-Jiang Li; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-09-23       Impact factor: 6.150

4.  Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.

Authors:  Jeremy M Van Raamsdonk; Zoe Murphy; Elizabeth J Slow; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2005-11-08       Impact factor: 6.150

5.  Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.

Authors:  Rona K Graham; Yu Deng; Elizabeth J Slow; Brendan Haigh; Nagat Bissada; Ge Lu; Jacqueline Pearson; Jacqueline Shehadeh; Lisa Bertram; Zoe Murphy; Simon C Warby; Crystal N Doty; Sophie Roy; Cheryl L Wellington; Blair R Leavitt; Lynn A Raymond; Donald W Nicholson; Michael R Hayden
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

6.  Nuclear targeting of mutant Huntingtin increases toxicity.

Authors:  M F Peters; F C Nucifora; J Kushi; H C Seaman; J K Cooper; W J Herring; V L Dawson; T M Dawson; C A Ross
Journal:  Mol Cell Neurosci       Date:  1999-08       Impact factor: 4.314

7.  The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.

Authors:  Ben Woodman; Rachel Butler; Christian Landles; Michelle K Lupton; Jamie Tse; Emma Hockly; Hilary Moffitt; Kirupa Sathasivam; Gillian P Bates
Journal:  Brain Res Bull       Date:  2006-12-05       Impact factor: 4.077

8.  Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts.

Authors:  Akira Sawa; Eiichiro Nagata; Siobhan Sutcliffe; Pratima Dulloor; Matthew B Cascio; Yuji Ozeki; Sophie Roy; Christopher A Ross; Solomon H Snyder
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

9.  Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

Authors:  V C Wheeler; J K White; C A Gutekunst; V Vrbanac; M Weaver; X J Li; S H Li; H Yi; J P Vonsattel; J F Gusella; S Hersch; W Auerbach; A L Joyner; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

10.  Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.

Authors:  Dongshan Yang; Chuan-En Wang; Bentian Zhao; Wei Li; Zhen Ouyang; Zhaoming Liu; Huaqiang Yang; Pei Fan; Ashley O'Neill; Weiwang Gu; Hong Yi; Shihua Li; Liangxue Lai; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2010-07-21       Impact factor: 6.150

View more
  28 in total

1.  Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.

Authors:  Megan Krench; J Troy Littleton
Journal:  Fly (Austin)       Date:  2013-09-10       Impact factor: 2.160

2.  Huntington's disease: flipping a switch on huntingtin.

Authors:  Erin R Greiner; X William Yang
Journal:  Nat Chem Biol       Date:  2011-06-17       Impact factor: 15.040

Review 3.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties.

Authors:  Rakesh Mishra; Cody L Hoop; Ravindra Kodali; Bankanidhi Sahoo; Patrick C A van der Wel; Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-09-18       Impact factor: 5.469

Review 5.  PolyQ disease: misfiring of a developmental cell death program?

Authors:  Elyse S Blum; Andrew R Schwendeman; Shai Shaham
Journal:  Trends Cell Biol       Date:  2012-12-08       Impact factor: 20.808

6.  Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

Authors:  Luana Naia; I Luísa Ferreira; Teresa Cunha-Oliveira; Ana I Duarte; Márcio Ribeiro; Tatiana R Rosenstock; Mário N Laço; Maria J Ribeiro; Catarina R Oliveira; Frédéric Saudou; Sandrine Humbert; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2014-05-20       Impact factor: 5.590

7.  Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.

Authors:  Brenda Huang; WenJie Wei; Guohao Wang; Marta A Gaertig; Yue Feng; Wei Wang; Xiao-Jiang Li; Shihua Li
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

8.  Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.

Authors:  Sébastien Marion; Nikhil M Urs; Sean M Peterson; Tatyana D Sotnikova; Jean-Martin Beaulieu; Raul R Gainetdinov; Marc G Caron
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

Review 9.  Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?

Authors:  Guylaine Hoffner; Philippe Djian
Journal:  Mol Neurobiol       Date:  2014-10-22       Impact factor: 5.590

10.  An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1.

Authors:  Zhiqiang Zheng; Aimin Li; Brandon B Holmes; Jayne C Marasa; Marc I Diamond
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.